Dana-Far­ber backed Neo­morph hunts 'un­drug­gable' pro­teins with new round of in­vestor cash for hires, de­vel­op­ment

Big in­vest­ments in pro­tein degra­da­tion, the process of un­lock­ing pre­vi­ous­ly “un­drug­gable” bind­ing sites for nov­el ther­a­peu­tics, are noth­ing new with some of phar­ma’s biggest play­ers …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.